WARREN CHUMLEY: Open Payments
NPI 1902853617 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,779 in 175 payments from 29 companies in 2025. Trend: 2023 $23,554 · 2024 $19,728 · 2025 $17,779
Speaker / faculty: $9,581Honoraria: $3,850Food & beverage: $3,278Travel & lodging: $920Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 76 | $11,651 |
| Axsome Therapeutics, Inc. | 2 | $3,876 |
| PFIZER INC. | 30 | $325 |
| Novartis Pharmaceuticals Corporation | 11 | $222 |
| Biogen, Inc. | 3 | $192 |
| Vanda Pharmaceuticals Inc. | 7 | $172 |
| Lundbeck LLC | 3 | $169 |
| Eisai Inc. | 3 | $159 |
| EMD Serono, Inc. | 2 | $121 |
| Novo Nordisk Inc | 1 | $119 |
Products named: BOTOX, UBRELVY, Symbravo, QULIPTA, NURTEC ODT, KESIMPTA, Leqembi, PONVORY.
Industry payments across KY — which companies pay providers there.
